Scarica l'app Stockscreener
10.56
0.19%
-0.02
Dopo l'orario di chiusura:
10.56
Precedente Chiudi:
$10.58
Aprire:
$10.56
Volume 24 ore:
132
Relative Volume:
0.01
Capitalizzazione di mercato:
$231.34M
Reddito:
-
Utile/perdita netta:
$6.36M
Rapporto P/E:
36.36
EPS:
0.2904
Flusso di cassa netto:
$-608.40K
1 W Prestazione:
-0.09%
1M Prestazione:
+0.19%
6M Prestazione:
+2.13%
1 anno Prestazione:
+4.76%
Intervallo 1D:
$10.56
$10.56
Intervallo di 1 settimana:
$10.56
$10.58
Portata 52W:
$10.07
$10.58
Translational Development Acquisition Corp Stock (TDAC) Company Profile
Nome
Translational Development Acquisition Corp
Settore
Industria
Telefono
(413) 204-2769
Indirizzo
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, MRLN, DMII, UMAC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.56 | 231.34M | 0 | 6.36M | -608.40K | 0.2904 |
LION
Lionsgate Studios Corp
|
9.63 | 2.79B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
6.16 | 2.13B | 0 | 4.35M | 456.40K | 0.3397 |
MRLN
Merlin Inc
|
8.27 | 696.85M | 0 | 0 | 0 | 0.00 |
DMII
Drugs Made In America Acquisition Ii Corp
|
9.99 | 655.09M | 0 | 0 | 0 | -0.0028 |
UMAC
Unusual Machines Inc
|
13.60 | 649.91M | 11.20M | -19.19M | -23.24M | -0.7527 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-21 | Iniziato | Northland Capital | Outperform |
Translational Development Acquisition Corp Borsa (TDAC) Ultime notizie
Spartacus Acquisition Corp. II Warrants (TMTSW) stock price, news, quote and history - Yahoo Finance Singapore
Opendoor Technologies Inc. (OPENW) stock price, news, quote and history - Yahoo Finance UK
symbol__ Stock Quote Price and Forecast - CNN
TDAC (NASDAQ: TDAC) details 2025 SPAC results, trust balance and June 2026 deadline - Stock Titan
Translational Development Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Stock List: Research Stocks from Around the World - GuruFocus
Tavia Acquisition Corp. (TAVI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Rally Mode: Is Ainos Inc a play on infrastructure spendingWeekly Risk Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Market Review: Can Translational Development Acquisition Corp outperform in the next rallyChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - StreetInsider
TDAC Should I Buy - Intellectia AI
Geopolitics Watch: Is Tapestry Inc a defensive stock2026 Historical Comparison & Daily Chart Pattern Signals - baoquankhu1.vn
Profit Recap: Is Qiagen NV part of any major indexShare Buyback & Stepwise Trade Execution Plans - baoquankhu1.vn
Gains Recap: Is Translational Development Acquisition Corp undervalued by DCF analysisPortfolio Return Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
TDAC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Update: Is Newbury Street II Acquisition Corp affected by consumer sentimentMarket Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Buy Signal: Can HUSA generate free cash flow2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn
Retail Trends: Will NCMI benefit from AI trends2026 WrapUp & Community Trade Idea Sharing - baoquankhu1.vn
Aug Macro: Is Translational Development Acquisition Corp attractive at current valuation2026 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn
Buy Signal: How liquid is TBCPW stock2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Volatility Watch: Is AEye Inc stock risky to hold nowTrade Exit Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Latest Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk
Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk
IPO Launch: Should you avoid TPST stock right nowAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Stock Recap: Is LCII a speculative investmentMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Movement Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsPortfolio Update Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Stock Analysis: Will CIMG Inc announce a stock split2025 Short Interest & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Published on: 2026-02-21 02:25:17 - mfd.ru
Published on: 2026-02-21 08:39:55 - baoquankhu1.vn
Volume Report: Is CICXU currently under institutional pressureEarnings Overview Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Axol Bioscience makes third acquisition in five years - Business Weekly
Axol Bioscience acquires ophthalmology business from Newcells Biotech - Cambridge Network
Can Translational Development Acquisition Corp. Equity Warrant stock double in next 5 yearsEntry Point & Daily Profit Maximizing Trade Tips - mfd.ru
Why Critical Metals Corp. stock could outperform in 2025Quarterly Market Review & Technical Entry and Exit Alerts - mfd.ru
Why NOVA stock remains resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Growth Review: What hedge funds are buying BJRIPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
What’s the profit margin of Translational Development Acquisition Corp.Share Buyback & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Will Translational Development Acquisition Corp. stock remain a Wall Street favoritePortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
What drives Translational Development Acquisition Corp.’s stock price2025 Trading Recap & Verified Swing Trading Watchlist - mfd.ru
Big Picture: What are ClearPoint Neuro Incs recent SEC filings showingIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
CEO Moves: Is Albany International Corps growth already priced in2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Aug Drivers: What is the dividend yield of QUALCOMM IncorporatedJuly 2025 Institutional & Long-Term Safe Return Strategies - baoquankhu1.vn
Risk On: Can PSAPRF outperform under higher oil pricesJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn
Will Zeta Global Holdings Corp. stock split attract more investors2025 Macro Impact & AI Forecast Swing Trade Picks - mfd.ru
Why is Translational Development Acquisition Corp. Equity Warrant stock going downMarket Growth Summary & Weekly Return Optimization Plans - mfd.ru
Aug Shorts: Is Translational Development Acquisition Corp. a potential multi baggerBull Run & Weekly Return Optimization Plans - baoquankhu1.vn
Large-scale multi-omics unveils host–microbiome interactions driving root development and nitrogen acquisition - Nature
Pullback Watch: Whats next for ALRS stockJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Published on: 2026-02-01 08:56:35 - baoquankhu1.vn
Energy Moves: Can Translational Development Acquisition Corp outperform in the next rallyWeekly Market Report & Stock Portfolio Risk Control - baoquankhu1.vn
Update Report: Is Translational Development Acquisition Corp undervalued by DCF analysisEarnings Growth Summary & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Translational Development Acquisition Corp Azioni (TDAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.53%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):